Heavy short interest and bullish technicals
CLOV currently has 15% of its float shorted, according to data from Yahoo Finance, a number that could be high enough to put the stock on the edge of a short squeeze.
Similarly, Is CLOV a short squeeze?
In the short term, the company remains heavily shorted and backed by a loyal ape community, which could put CLOV on the edge of new short squeezes. According to Yahoo Finance, nearly 30 million shares are shorted out of a float of 112 million (representing 25%).
Why is CLOV so low? Known as the “king of SPACs,” Clover saw its stock price plummet earlier this year. The likely culprit: research firm Hindenburg shorted the stock, claiming that the company was the target of an investigation for dubious sales practices.
Thereof, What percentage of CLOV is shorted?
| Short Interest | shares – source: NASDAQ |
|---|---|
| Short Interest Ratio | 1.62 Days to Cover |
| Short Interest % Float | 11.01% – source: NASDAQ (short interest), Capital IQ (float) |
| Off-Exchange Short Volume | 3,256,141 shares – source: FINRA (inc. Dark Pool volume) |
| Off-Exchange Short Volume Ratio | 48.46% – source: FINRA (inc. Dark Pool volume) |
Why is CLOV stock up?
Right now, CLOV stock is up in response to Clinton’s purchase, which investors are viewing as a positive signal. Often times, director trading activity like this is important to track because insiders often have a better view of a company’s long-term growth potential than retail investors.
Why is CLOV a meme stock?
Why Clover Health reached “meme stock” status
When Clover Health stock declined in prices following the report from short seller Hindenburg Research, meme stock traders took notice. Clover Health’s negative reports hit the media, claiming that investors were misled by lack of transparency in the DOJ investigation.
Is CLOV undervalued?
CLOV earnings show improving profitability and promising 2022 guidance. Q4 results carry some evidence that CLOV’s profitability issues were temporary. At current prices, the company is undervalued, despite its above-average growth.
Does Citadel own CLOV?
2022-02-14 – Citadel Advisors Llc has filed a 13F-HR form disclosing ownership of 3,589,146 shares of Clover Health Investments Corp Class A (US:CLOV) with total holdings valued at $13,352,000 USD as of 2021-12-31.
Will Clover recover?
Clover Health stumbled out of the gate. It failed to disclose a government investigation into its business. Shares dropped by nearly half as short sellers revealed that fact. Subsequently, Clover has failed to recover.
Who owns CLOV float?
CLOV Stock Price | Clover Health Investments Corp. Cl A Stock Quote (U.S.: Nasdaq) | MarketWatch.
Is Clover Health a pump and dump?
Like most pump-and-dump schemes, shares of Clover Health are doomed to decline after the excitement fizzles out. Clover Health is overvalued and has extreme risk.
Will clover stock recover?
Clover Health stumbled out of the gate. It failed to disclose a government investigation into its business. Shares dropped by nearly half as short sellers revealed that fact. Subsequently, Clover has failed to recover.
Is CLOV stock undervalued?
CLOV earnings show improving profitability and promising 2022 guidance. Q4 results carry some evidence that CLOV’s profitability issues were temporary. At current prices, the company is undervalued, despite its above-average growth.
Is Clover a buy?
Hands down the most important reason to buy Clover Health now is the trend toward an improved medical care ratio (MCR). The amount Clover Health shells out to providers is expected to fall significantly this year to a range between 95% and 99% of premiums collected.
Is Clover Health A Good Investment?
If you’re interested in a speculative investment that could blow up over the next decade, Clover Health is worth a buy today, though it’s quite risky for an insurance company.
Is Clover Health profitable?
For full-year 2022, Clover Health is providing the following guidance and commentary: Total revenues are expected to be in the range of $3.0 billion to $3.4 billion. This includes projected MA revenue of $1.0 billion to $1.1 billion and Direct Contracting revenue of $2.0 billion to $2.3 billion.
Is Clover Health a good company?
Clover Health Reviews FAQs
Is Clover Health a good company to work for? Clover Health has an overall rating of 4.1 out of 5, based on over 178 reviews left anonymously by employees. 77% of employees would recommend working at Clover Health to a friend and 78% have a positive outlook for the business.
Who owns CLOV?
Largest shareholders include Vanguard Group Inc, Greenoaks Capital Partners Llc, VTSMX – Vanguard Total Stock Market Index Fund Investor Shares, Baillie Gifford & Co, NAESX – Vanguard Small-Cap Index Fund Investor Shares, Two Sigma Investments, Lp, Pnc Financial Services Group, Inc., BlackRock Inc., Ghisallo Capital …
How much of CLOV is owned by Citadel?
Top 10 Owners of Clover Health Investments Corp
| Stockholder | Stake | Total change |
|---|---|---|
| Susquehanna Financial Group LLLP | 1.29% | -19.80% |
| BlackRock Fund Advisors | 1.26% | +44.50% |
| Two Sigma Advisers LP | 1.16% | +11,453.30% |
| Citadel Advisors LLC | 0.95% | +605.90% |
Who bought CLOV?
Director Chelsea Clinton bought up a large block of shares of the digital-first Medicare Advantage insurer. Clover Health (ticker: CLOV) stock has dropped 41% so far this year, compared with a 9.2% slip in the S&P 500 index.
Join TheMoney.co community and don’t forget to share this post !
